Omnicell, Inc. OMCL
33.66
0.67
2.03%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 39.5×
Follow OMCL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
48.85 | 75.86 | 1,132.50 | 70.81 |
+8 more quarters Free account |
P/S ratio |
1.52 | 1.23 | 1.76 | 1.18 | |
P/FCF ratio |
14.94 | 15.47 | 30.02 | 14.79 | |
P/Operating CF |
27.72 | 27.76 | 68.60 | 49.06 | |
P/B ratio |
1.47 | 1.20 | 1.69 | 1.14 | |
Price to Tangible BV |
4.81 | 4.27 | 6.43 | 4.46 | |
EV/Sales |
1.56 | 1.32 | 1.88 | 1.32 | |
EV/EBITDA |
13.45 | 13.32 | 23.59 | 14.44 | |
EV/Operating CF |
10.72 | 10.37 | 17.50 | 10.11 | |
EV/FCF |
15.34 | 16.52 | 32.12 | 16.52 | |
Quick Ratio |
1.16 | 1.01 | 0.87 | 0.93 | |
Current Ratio |
1.64 | 1.50 | 1.43 | 1.44 | |
Net Debt/EBITDA |
(2.31) | (1.88) | (1.27) | (0.42) | |
Debt/Assets |
8.41% | 8.38% | 8.49% | 8.59% | |
Debt/Equity |
0.13 | 0.13 | 0.14 | 0.14 | |
Asset Turnover |
0.60 | 0.59 | 0.58 | 0.55 | |
Operating CF/Net income |
2.81 | 4.80 | (14.98) | 5.18 | |
Capex/Depreciation |
(0.59) | (0.76) | (0.54) | (0.65) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.50% | 6.94% | 7.18% | 7.73% | |
Selling, General and Administrative Expense of Revenue |
32.09% | 32.91% | 34.19% | 32.91% | |
Intangible Assets out of Total Assets |
0.45 | 0.45 | 0.46 | 0.47 | |
Share Based Compensation of Revenue |
3.91% | 3.07% | 3.81% | 3.61% | |
Graham Net Nets |
0.01 | (0.02) | (0.03) | (0.05) | |
Graham Number |
23.27 | 16.57 | 4.91 | 16.11 | |
Earnings Yield |
2.05% | 1.32% | 0.09% | 1.41% | |
Free Cash Flow Yield |
6.69% | 6.47% | 3.33% | 6.76% | |
Revenue per Share |
6.85 | 6.84 | 6.83 | 6.82 | |
Operating CF per Share |
1.50 | 1.20 | 0.66 | 0.62 | |
Capex per Share |
(0.27) | (0.35) | (0.26) | (0.31) | |
Free Cash Flow per Share |
1.22 | 0.85 | 0.40 | 0.31 | |
Cash per Share |
6.41 | 5.28 | 4.28 | 3.95 | |
Shareholders Equity per Share |
28.32 | 27.73 | 26.80 | 26.81 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.32 | 27.73 | 26.80 | 26.81 | |
Free Cash Flow |
55.78 | 38.63 | 18.36 | 13.99 | |
Working Capital |
287.95 | 239.25 | 203.46 | 203.03 | |
Capital Expenditures |
(12.53) | (15.87) | (11.99) | (14.28) | |
Net Current Asset Value |
28.13 | (25.17) | (62.84) | (68.07) | |
EV/EBIT |
33.55 | 48.06 | 431.81 | 90.35 | |
Capex to Sales |
0.04 | 0.05 | 0.04 | 0.05 | |
Net Profit Margin |
7.78% | 3.67% | (0.65%) | 1.76% | |
Price to Operating Income |
32.67 | 44.98 | 403.54 | 80.90 | |
| Other line items | |||||
Average Receivables |
229.87 | 250.70 | 236.63 | 248.74 | |
Average Payables |
56.10 | 55.81 | 47.89 | 55.15 | |
Average Inventory |
101.25 | 95.17 | 94.78 | 101.24 | |
Average Assets |
2,072.18 | 2,077.79 | 2,047.84 | 2,126.09 | |
Average Common Equity |
1,277.61 | 1,256.87 | 1,237.56 | 1,226.12 |
Columns are period end dates